Antagonizing the errors of history: bedside experience with flumazenil

References

• Proudfoot AT, Park J. Changing pattern of drugs used for self-poisoning. Br Med J. 1978;1(6105):90–93.
   Google Scholar
• Henderson A, Wright M, Pond SM. Experience with 732 acute overdose patients admitted to an intensive care unit over six years. Med J Aust. 1993;158(1):28–30.
   PubMed Web of Science ®Google Scholar
• Hunkeler W, Mohler H, Pieri L, et al. Selective antagonists of benzodiazepines. Nature. 1981;290(5806):514–516.
   PubMed Web of Science ®Google Scholar
• Ngo AS, Anthony CR, Samuel M, et al. Should a benzodiazepine antagonist be used in unconscious patients presenting to the emergency department? Resuscitation. 2007;74(1):27–37.
   PubMed Web of Science ®Google Scholar
• Ashton CH. Benzodiazepine overdose: are specific antagonists useful. Br Med J (Clin Res Ed). 1985;290(6471):805–806.
   Google Scholar
• Spivey WH, Roberts JR, Derlet RW. A clinical trial of escalating doses of flumazenil for reversal of suspected benzodiazepine overdose in the emergency department. Ann Emerg Med. 1993;22(12):1813–1821.
   PubMed Web of Science ®Google Scholar
• Gueye PN, Hoffman JR, Taboulet P, et al. Empiric use of flumazenil in comatose patients: limited applicability of criteria to define low risk. Ann Emerg Med. 1996;27(6):730–735.
   PubMed Web of Science ®Google Scholar
• Spivey WH. Flumazenil and seizures: analysis of 43 cases. Clin Ther. 1992;14(2):292–305.
   PubMed Web of Science ®Google Scholar
• Wolf BC, Lavezzi WA, Sullivan LM, et al. Alprazolam-related deaths in Palm Beach County. Am J Forensic Med Pathol. 2005;26(1):24–27.
   Web of Science ®Google Scholar
• Wunsch MJ, Nakamoto K, Behonick G, et al. Opioid deaths in rural Virginia: a description of the high prevalence of accidental fatalities involving prescribed medications. Am J Addict. 2009;18(1):5–14.
   PubMed Web of Science ®Google Scholar
• Mowry JB, Spyker DA, Cantilena LR, Jr, et al. 2013 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st Annual Report. Clin Toxicol (Phila). 2014;52(10):1032–1283.
   PubMed Web of Science ®Google Scholar
• Riker RR, Picard JT, Fraser GL. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med. 1999;27(7):1325–1329.
   PubMed Web of Science ®Google Scholar
• Moore PW, Donovan JW, Burkhart KK, et al. Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center. J Med Toxicol. 2014;10(2):126–132.
   Google Scholar
• Vasilevskis EE, Han JH, Hughes CG, et al. Epidemiology and risk factors for delirium across hospital settings. Best Pract Res Clin Anaesthesiol. 2012;26(3):277–287.
   PubMedGoogle Scholar
• Stewart SA. The effects of benzodiazepines on cognition. J Clin Psychiatry. 2005;66(Suppl 2):9–13.
   PubMed Web of Science ®Google Scholar
• Kallin K, Jensen J, Olsson LL, et al. Why the elderly fall in residential care facilities, and suggested remedies. J Fam Pract. 2004;53(1):41–52.
   PubMed Web of Science ®Google Scholar
• Mowry JB, Spyker DA, Cantilena LR, Jr, et al. Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS):30th Annual Report. Clin Toxicol (Phila). 2013;51(10):949–1229.
   PubMed Web of Science ®Google Scholar
• Kreshak AA, Cantrell FL, Clark RF, et al. poison center’s ten-year experience with flumazenil administration to acutely poisoned adults. J Emerg Med. 2012;43(4):677–682.
   PubMed Web of Science ®Google Scholar
• Penninga EI, Graudal N, Ladekarl MB, et al. Adverse events associated with flumazenil treatment for the management of suspected benzodiazepine intoxication–A systematic review with meta-analyses of randomised trials. Basic Clin Pharmacol Toxicol. 2016;118(1):37–44.
   PubMed Web of Science ®Google Scholar
• Tintinalli JE, Cline D, eds. Tintinalli’s emergency medicine manual. New York: McGraw-Hill Medical; 2012.
   Google Scholar
• Yealy DM, Callaway C, eds. Emergency department critical care. New York: Oxford University Press; 2013.
   Google Scholar
• Haefely W. The preclinical pharmacology of flumazenil. Eur J Anaesthesiol. 1988;2:25–36.
   Google Scholar
• Brogden RN, Goa KL. A preliminary review of its benzodiazepine antagonist properties, intrinsic activity and therapeutic use. Drugs. 1988;35(4):448–467.
   Web of Science ®Google Scholar
• Nutt DJ, Malizia AL. New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry. 2001;179(5):390–396.
   PubMed Web of Science ®Google Scholar
• Savic I, Widén L, Stone-Elander S. Feasibility of reversing benzodiazepine tolerance with flumazenil. Lancet. 1991;337(8734):133–137.
   Web of Science ®Google Scholar
• Granja C, Gomes E, Amaro A, et al. Understanding posttraumatic stress disorder-related symptoms after critical care: the early illness amnesia hypothesis. Crit Care Med. 2008;36:2801–2809.
   Web of Science ®Google Scholar
• Davydow DS. Symptoms of depression and anxiety after delirium. Psychosomatics. 2009;50(4):309–316.
   Web of Science ®Google Scholar
• Myhren H, Ekeberg O, Tøien K, et al. Posttraumatic stress, anxiety and depression symptoms in patients during the first year post intensive care unit discharge. Crit Care. 2010;14(1):R14.
   Web of Science ®Google Scholar
• Davydow DS, Gifford JM, Desai SV, et al. Posttraumatic stress disorder in general intensive care unit survivors: a systematic review. Gen Hosp Psychiatry. 2008;30(5):421–434.
   PubMed Web of Science ®Google Scholar
• Pandharipande P, Shintani A, Peterson J, et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology. 2006;104(1):21–26.
   PubMed Web of Science ®Google Scholar
• Buczko GB. Sedation in critically ill patients: a review. Med Health R I. 2001;84(10):321–323.
   Google Scholar
• Dominguez KD, Crowley MR, Coleman DM, et al. Withdrawal from lorazepam in critically ill children. Ann Pharmacother. 2006;40(6):1035–1039.
   Web of Science ®Google Scholar
• Weinbroum A, Rudick V, Sorkine P, et al. Use of flumazenil in the treatment of drug overdose: a double-blind and open clinical study in 110 patients. Crit Care Med. 1996;24(2):199–206.
   PubMed Web of Science ®Google Scholar
• Weinbroum AA, Flaishon R, Sorkine P, et al. A risk-benefit assessment of flumazenil in the management of benzodiazepine overdose. Drug Saf. 1997;17(3):181–196.
   PubMed Web of Science ®Google Scholar